ERIK MILLER: Open Payments
NPI 1063042596 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 30 payments from 16 companies in 2025. Trend: 2023 $962 · 2024 $859 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| PFIZER INC. | 3 | $65 |
| ABBVIE INC. | 3 | $62 |
| Lilly USA, LLC | 4 | $61 |
| IBSA Pharma Inc. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Hologic Sales and Service, LLC | 1 | $27 |
Products named: SHINGRIX, NURTEC ODT, MOUNJARO, QULIPTA, Tirosint, Wegovy, XYOSTED, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve.
Industry payments across CO — which companies pay providers there.
